Assignee
BIOGNOSTIK GES
DE·5 granted patents·1 pending application·80 citations·filing 1994–2006
Top patents by PatentIndex Score
6 records- 0188US7667027B2Antisense-oligonucleotides for the treatment of immuno-suppressive effects of transforming growth factor-β (TGF-β)BIOGNOSTIK GES·Filed 2006·Granted Feb 23, 2010·15 cites·2 claims
- 0284US6455689B1Antisense-oligonucleotides for transforming growth factor-β (TGF-β)BIOGNOSTIK GES·Filed 1994·Granted Sep 24, 2002·49 cites·6 claims
- 0366US7563778B2Antisense oligonucleotide preparation methodBIOGNOSTIK GES·Filed 2004·Granted Jul 21, 2009·2 cites·5 claims
- 0458US6972171B1Antisense oligonucleotide preparation methodBIOGNOSTIK GES·Filed 1998·Granted Dec 6, 2005·14 cites·9 claims
- 0548US2003040499A1Antisense-oligonucleotides for the treatment of immuno-suppressive effects of transforming growth factor-beta (TGF-beta)BIOGNOSTIK GES·Filed 2002·Application pending·0 cites
- 0628US7326783B2Pharmaceutical composition comprising antisense-nucleic acid for prevention and/or treatment of neuronal injury, degeneration and cell death and for the treatment of neoplasmsBIOGNOSTIK GES·Filed 1994·Granted Feb 5, 2008·0 cites·2 claims
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →